- Weigao Medical Polymer revised and adopted a Board Diversity Policy on March 27, 2026.
- The policy states that board appointments will be based on merit while taking diversity, including gender diversity, into account.
- Nomination Committee reviews of board structure, size, and composition are to be conducted at least annually, considering factors such as skills, experience, independence, age, and gender.
- The company said it will ensure the board is not composed of a single gender.
- Progress against any measurable diversity objectives, if set, is to be disclosed annually in the corporate governance report in the annual report.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shandong Weigao Group Medical Polymer Co. Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260327-12073397), on March 27, 2026, and is solely responsible for the information contained therein.
Comments